Ignite Creation Date:
2024-05-06 @ 3:21 PM
Last Modification Date:
2024-10-26 @ 1:48 PM
Study NCT ID:
NCT04606498
Status:
UNKNOWN
Last Update Posted:
2022-11-01
First Post:
2020-10-26
Brief Title:
Blood Purification With Seraph 100 Microbind Affinity Blood Filter for Treatment of Severe COVID19 Observational Study
Sponsor:
Organization:
Henry M Jackson Foundation for the Advancement of Military Medicine
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITHOUT_DNA
Bio Spec Description:
Biospecimen blood urine sputum swabs will be collected at D0 before initiation of extracorporeal treatment and on study days 1 2 3 4 7 28 and 90-180 Since a goal of this study is to recruit as many subjects as possible predominantly for safety purposes if a patient is started on Seraph 100 prior to being recruited for the study lab collection will begin at the next time point For example if a patient is started on Seraph 100 on a Sunday and the patient is not enrolled until Monday study day 0 labs will be marked as missing and lab collection will begin on study day 1
Enrollment Count:
200
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 69540 |
Who Masked List: